| GSK's Votrient gets conditional OK in Europe for renal cancer - Pharma Times |
|
|
Pharma TimesThe European Commission has granted a conditional marketing authorisation for Votrient (pazopanib) for the first-line treatment of advanced renal cell ... read more |